PreprintCC BY-NC-NDChemRxiv
ChemEidos: Synthesis-Aware Multimodal Foundation Models for Domain-Specific Generative Design
Abstract
Generative artificial intelligence models for de novo drug discovery often suffer synthetic tractability issues and lack fidelity in underrepresented chemical domains. This white paper highlights ChemEidos, a novel multimodal generative design platform that utilizes the underlying patterns, forms, and organizing principles of chemical space (eidos) by incorporating expert domain knowledge in focused training sets and at inference time.
Related
- Generative and Foundation-Model Artificial Intelligence in Food Safety Analysis, Authenticity Identification, and Quality Control: A Systematic Review of Validation and Decision Readiness.
- Domain-Informed AI Multimodal Foundation Model for Materials Science
- A Full-Spectrum Generative Lead Discovery (FSGLD) pipeline via DRUG-GAN: A multiscale method for drug-like/target-specific compound library generation
- Multimodal LLM-Assisted Diagnosis of Cryptic Failure Modes in High-Throughput Experimentation: A Case Study in Gold Nanorod Synthesis
- Adaptation of a retrosynthetic tool to project-specific chemistry: oligomer synthesis case study
BibTeX
@misc{remington2026chemeidos,
title = {{ChemEidos: Synthesis-Aware Multimodal Foundation Models for Domain-Specific Generative Design}},
author = {Jacob M. Remington and Elizabeth H. Frush and David A. Pardoe and William R. Pitt and Irene Pitard and Laetitia Breuil},
howpublished = {ChemRxiv},
year = {2026},
month = oct,
doi = {10.26434/chemrxiv.15010851/v1},
url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15010851/v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - ChemEidos: Synthesis-Aware Multimodal Foundation Models for Domain-Specific Generative Design
AU - Jacob M. Remington
AU - Elizabeth H. Frush
AU - David A. Pardoe
AU - William R. Pitt
AU - Irene Pitard
AU - Laetitia Breuil
PY - 2026
DA - 2026/10/22
PB - ChemRxiv
DO - 10.26434/chemrxiv.15010851/v1
UR - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15010851/v1
AB - Generative artificial intelligence models for de novo drug discovery often suffer synthetic tractability issues and lack fidelity in underrepresented chemical domains. This white paper highlights ChemEidos, a novel multimodal generative design platform that utilizes the underlying patterns, forms, and organizing principles of chemical space (eidos) by incorporating expert domain knowledge in focused training sets and at inference time.
ER -